Results 191 to 200 of about 62,320 (268)

Poor efficacy of the combination of clarithromycin, amikacin, and cefoxitin against Mycobacterium abscessus in the hollow fiber infection model [PDF]

Etienne Vignaud, Sylvain Goutelle, Charlotte Genestet, Jérôme Guitton, Sabine Cohen, Chloé Bourg, Aurore Durand, Laura Lebouteiller, Albin Bernard, C Richet, Oana Dumitrescu, Elisabeth Hodille   +11 more
openalex   +1 more source

Determinants of <i>Helicobacter pylori</i> infection and eradication failure among healthcare workers in a high-exposure clinical setting: a single-centre retrospective cohort study in China. [PDF]

BMJ Open
Xie D, Cheng J, Zhao X, Fan C.
europepmc   +1 more source

High Prevalence of <i>hefA</i> Efflux Pump Overexpression in Isolates of <i>Helicobacter pylori</i> Resistant to Clarithromycin. [PDF]

Antibiotics (Basel)
Villegas M, Ortega C, Gómez K, Cerda A, Sepúlveda R, Lara C, Bustamante L, Garcia D, Coppelli L, Hofmann E, Sierralta A, Pavez M.   +11 more
europepmc   +1 more source

Formulation and In Vitro evaluation of pH sensitive oil entrapped polymeric blended gellan gum buoyant beads of clarithromycin.

, 2010
Girish Kumar Tripathi, S. Singh
openalex   +1 more source

Clarithromycin attenuates autophagy in myeloma cells

, 2010
Hata
openalex   +2 more sources

Whole genome sequence analysis of <i>Helicobacter pylori</i> isolates reveals incomplete characterization of antimicrobial resistance mechanisms. [PDF]

iScience
Vieni C, Rothstein T, Johnson S, Schuetz AN, Norgan A, Patel R.   +5 more
europepmc   +1 more source

Ranking prescribed pharmaceuticals in terms of environmental risk: inclusion of hospital data and the importance of regular review [PDF]

, 2016
De Souza, Escher, Hamer, Huber, Huschek, Jones, Kuo, Kümmerer, Kümmerer, Kümmerer, Lienert, Mehinto, Ort, Ort, Parolini, Santos, Schuster, Sebastine, Verlicchi, Verlicchi, Weissbrodt   +20 more
core   +1 more source

Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer

, 2019
Giulia Petroni, Matteo Stefanini, Serena Pillozzi, Olivia Crociani, Andrea Becchetti, Annarosa Arcangeli   +5 more
openalex   +1 more source

Comparison between optimized bismuth quadruple therapy and standard clarithromycin-based triple therapy for first-line <i>Helicobacter pylori</i> eradication: a double-blind randomized controlled trial. [PDF]

Lancet Reg Health Am
Medel-Jara PA, Latorre G, Fuentes-Lopez E, Pizarro M, Viviani P, Chahuán J, Maquilón S, Corsi O, Reyes D, Espino A, Vargas JI, Wichmann IA, Harris P, Serrano C, Buruato I, Sandoval C, Varela NM, Cerpa L, Quiñones L, Megraud F, Huang RJ, Shah SC, Perez AR.   +22 more
europepmc   +1 more source